{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:02:38Z","timestamp":1649142158642},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T00:00:00Z","timestamp":1410220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0107515","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T18:05:24Z","timestamp":1410285924000},"page":"e107515","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Does Variation among Provincial Drug Formulary Antimicrobial Listings in Canada Influence Prescribing Rates?"],"prefix":"10.1371","volume":"9","author":[{"given":"Shiona K.","family":"Glass-Kaastra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Finley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Conly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,9,9]]},"reference":[{"key":"ref1","first-page":"705","article-title":"Do provincial drug benefit initiatives create an effective policy lab? The evidence from Canada","volume":"35(5)","author":"MP Pomey","year":"2020","journal-title":"J Health Polit Policy Law"},{"key":"ref2","unstructured":"Canadian Agency for Drugs and Technologies in Health (CADTH) (2012) About the common drug review. Available: http:\/\/cadth.ca\/en\/products\/cdr\/cdr-overview<\/ext-link>. Accessed May 23, 2012."},{"key":"ref3","unstructured":"Ontario Ministry of Health and Long-Term Care (2011) Ontario Drug Benefit Program: Limited use drug products. Available: http:\/\/www.health.gov.on.ca\/en\/public\/programs\/drugs\/programs\/odb\/opdp_limited_use.aspx<\/ext-link>. Accessed May 2, 2012."},{"key":"ref4","unstructured":"Qu\u00e9bec R\u00e9gie de L'assurance maladie. (2011) Demande D'autorisation de paiement: M\u00e9dicament d'exception. Available: http:\/\/www.ramq.gouv.qc.ca\/sitecollectiondocuments\/professionnels\/formulaires\/3633.pdf<\/ext-link>. Accessed May 2, 2012."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.amjmed.2007.02.028","article-title":"Impact of a fluoroquinolone restriction policy in an elderly population","volume":"120","author":"M Mamdani","year":"2007","journal-title":"Am J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/jama.280.14.1270","article-title":"Antibiotic resistance \u2013 squeezing the balloon?","volume":"280","author":"JP Burke","year":"1998","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00005650-200104000-00003","article-title":"A dog's breakfast: prescription drug coverage varies widely across Canada","volume":"39","author":"AH Anis","year":"2001","journal-title":"Med Care"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/cid\/cir409","article-title":"Impact of a multipronged education strategy on antibiotic prescribing in Qu\u00e9bec, Canada","volume":"53","author":"K Weiss","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref9","unstructured":"Government of Alberta Health and Wellness. (2011) Alberta Health and Wellness Drug Benefit List. Available: https:\/\/www.ab.bluecross.ca\/dbl\/pdfs\/ahwdbl_april_list.pdf<\/ext-link>. Accessed November 28, 2011."},{"key":"ref10","unstructured":"British Columbia Ministry of Health Services. (2011) PharmaCare Formulary Search. Available: http:\/\/www.health.gov.bc.ca\/pharmacare\/benefitslookup\/faces\/Search.jsp<\/ext-link>. Accessed November 28, 2011."},{"key":"ref11","unstructured":"Manitoba Health. Manitoba Pharmacare Program Drug Formulary Lookup. (2011) Available: http:\/\/web6.gov.mb.ca\/eFormulary\/<\/ext-link>. Accessed November 28, 2011."},{"key":"ref12","unstructured":"New Brunswick Department of Health. (2011) Prescription drug program Formulary. Available: http:\/\/www.gnb.ca\/0212\/pdf\/NBPDP_Formulary\/2012\/NBPDPFormularyMarch2012english.pdf<\/ext-link>. Accessed November 28, 2011."},{"key":"ref13","unstructured":"Newfoundland and Labrador Department of Health and Community Services. (2011) Prescription Drug Program NLPDP Coverage Status Table. Available: http:\/\/www.health.gov.nl.ca\/health\/prescription\/coverage_status_table.pdf<\/ext-link>. Accessed November 28, 2011."},{"key":"ref14","unstructured":"Nova Scotia Pharmacare. (2011) Drug Formulary. Available: http:\/\/www.gov.ns.ca\/health\/Pharmacare\/formulary.pdf<\/ext-link>. Accessed November 28, 2011."},{"key":"ref15","unstructured":"Ontario Ministry of Health and Long-Term Care. (2011) Ontario Drug Benefit Formulary\/Comparative drug index. Available: https:\/\/www.healthinfo.moh.gov.on.ca\/formulary\/index.jsp<\/ext-link>. Accessed November 28, 2011."},{"key":"ref16","unstructured":"Health PEI. (2011) PEI Pharmacare Formulary. Available: http:\/\/www.gov.pe.ca\/photos\/original\/hpei_formulary.pdf<\/ext-link>. Accessed November 28, 2011."},{"key":"ref17","unstructured":"R\u00e9gie de l'assurance maladie Qu\u00e9bec. (2011) List of Medications. Available: https:\/\/www.prod.ramq.gouv.qc.ca\/DPI\/PO\/Commun\/PDF\/Liste_Med\/Liste_Med\/liste_med_2011_10_03_en.pdf<\/ext-link>. Accessed November 28, 2011."},{"key":"ref18","unstructured":"Saskatchewan Ministry of Health. (2011) Drug plan Formulary Edition 61. Available: http:\/\/formulary.drugplan.health.gov.sk.ca\/publications\/Formularyv61.pdf<\/ext-link>. Accessed November 28, 2011."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e76398","DOI":"10.1371\/journal.pone.0076398","article-title":"Declines in outpatient antimicrobial use in Canada (1995\u20132010)","volume":"8(10)","author":"R Finley","year":"2013","journal-title":"PLoS ONE"},{"key":"ref20","unstructured":"World Health Organization. (2014) ATC\/DDD Index. Available: http:\/\/www.whocc.no\/atc_ddd_index\/Accessed<\/ext-link> March 14, 2014."},{"key":"ref21","unstructured":"Alberta Health and Wellness. (2012) Alberta health and wellness drug benefit list: special authorization guidelines. Available: https:\/\/www.ab.bluecross.ca\/dbl\/pdfs\/ahwdbl_sec1_sa.pdf<\/ext-link>. Accessed May 2, 2012."},{"key":"ref22","unstructured":"British Columbia Ministry of Health. (2011) Limited coverage drug plan criteria information. Available: http:\/\/www.health.gov.bc.ca\/pharmacare\/sa\/criteria\/restricted\/restrictedtable.html<\/ext-link>. Accessed May 2, 2012."},{"key":"ref23","unstructured":"Government of Manitoba. (2012) Manitoba drug benefits and interchangeability formulary: Part 3- Exception drug status. Available: http:\/\/www.gov.mb.ca\/health\/mdbif\/docs\/edsnotice.pdf<\/ext-link>. Accessed May 2, 2012."},{"key":"ref24","unstructured":"New Brunswick Department of Health. (2012) Prescription drug program special authorization. Available: http:\/\/www.gnb.ca\/0212\/SpecialAuthorization-e.asp<\/ext-link>. Accessed May 2, 2012."},{"key":"ref25","unstructured":"Nova Scotia Pharmacare. (2012) Criteria for exception status coverage. Available: http:\/\/www.gov.ns.ca\/health\/Pharmacare\/pubs\/Criteria_for_Exception_Status_Coverage.pdf<\/ext-link>. Accessed May 2, 2012."},{"key":"ref26","unstructured":"Newfoundland and Labrador Department of Health and Community Services. (2012) The Newfoundland and Labrador Prescription Drug Program: Criteria for the coverage of special authorization drugs. Available: http:\/\/www.health.gov.nl.ca\/health\/nlpdp\/criteria.pdf<\/ext-link>. Accessed May 2, 2012."},{"key":"ref27","unstructured":"Health Prince Edward Island. (2012) P.E.I. Pharmacare formulary. Available: http:\/\/www.gov.pe.ca\/photos\/original\/hpei_formulary.pdf<\/ext-link>. Accessed May 2, 2012."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1155\/2014\/703898","article-title":"Variation in outpatient oral antimicrobial use patterns among Canadian provinces, 2000 to 2010)","volume":"25","author":"SK Glass-Kaastra","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF03405330","article-title":"Impact of administrative restrictions on trends in antibiotic resistance","volume":"97","author":"DA Marshall","year":"2006","journal-title":"Can J Public Health"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1000084","article-title":"Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002\u20132007","volume":"6","author":"E Sabuncu","year":"2009","journal-title":"PLoS Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1155\/2011\/745090","article-title":"Evaluation of the Do Bugs Need Drugs? program in British Columbia: Can we curb antibiotic prescribing?","volume":"22","author":"RM McKay","year":"2011","journal-title":"Can J Infect Dis Med Microbiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0107515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T06:17:48Z","timestamp":1598249868000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0107515"}},"subtitle":[],"editor":[{"given":"Dermot","family":"Cox","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,9]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0107515","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,9]]}}}